Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingyi Zhu
Institutions:
Second Affiliated Hospital of Nanjing Medical University,
Nanjing Medical University
Observed institutions:
Nanjing University of Chinese Medicine,
Second Affiliated Hospital of Nanjing Medical University,
Nanjing Medical University
ORCID:
0009-0002-9570-2891
Observed ORCID:
0009-0002-9570-2891
OpenAlex ID:
A5136539373
CircZNF609 inhibited bladder cancer immunotherapy sensitivity via enhancing fatty acid uptake through IGF2BP2/CD36 pathway
2024
·
Kai Li
, Jiancheng Lv
, et al.
·
International Immunopharmacology
·
24
N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer
2025
·
Kai Li
, Yongshan Li
, et al.
·
Biochemical Pharmacology
·
16
Decoding lactylation landscapes: Metabolic-epigenetic crosstalk through histone/non-histone modifications as drivers of disease progression and treatment resistance
2025
·
Zhida Chen
, Kai Li
, et al.
·
Biochemical and Biophysical Research Communications
·
11
EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer
2026
·
Kai Li
, Yong Wei
, et al.
·
Advanced Science
·
3
PDF
SUMOylation and palmitoylation in metastatic prostate cancer: A compartment-based framework for nuclear and membrane adaptation
2026
·
Shuangyu Ji
, Shiyu Li
, et al.
·
Biochemical and Biophysical Research Communications
Noncanonical function of Claudin-1 mitigates lethal endoplasmic reticulum stress to drive prostate cancer lineage plasticity and chemoresistance
2026
·
Youjian Li
, Yongshan Li
, et al.
·
Cellular and Molecular Life Sciences
Fueling death: Glucose metabolic reprogramming regulates ferroptosis and cuproptosis in cancer
2026
·
Yong Zhang
, Zhida Chen
, et al.
·
Biochemical and Biophysical Research Communications
Show more works
View as search
Works count:
7
Citation count:
54
H-index:
3
I10-index:
3
Year
Topic
Type